Ask AI
ProCE Banner Series

2025 Cardiology Intensive for Advanced Practice Providers

This dynamic half-day program is designed for nurse practitioners and physician associates, featuring expert-led presentations that delve into the latest advancements and best practices in cardiology. Participants will enhance their clinical knowledge and skills, empowering them to provide optimal care for patients with cardiovascular conditions and earn CE/CME credit.

  AAPA
  | ANCC
Who Should Attend

This activity is intended for cardiology-focused nurse practitioners, physician associates, clinical nurse specialists, and advanced degree nurses.

All Events

2025 Cardiology Intensive for Advanced Practice Providers

Upcoming Events

December

06

2025

10:00 AM - 3:20 PM Eastern Time (ET)

Virtual

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact Customer Support prior to the live event.

CME/CE Info

Goal Statement
The goal of this activity is to improve the knowledge and competence of learners who care for patients with cardiology conditions.

Target Audience
This activity is intended for cardiology-focused nurse practitioners, physician associates, clinical nurse specialists, and advanced degree nurses.

Learning Objectives
Upon completion of this activity, participants should be able to:

Leading With Impact: NPs and PAs at the Center of PAH Care Transformation

  • Differentiate key pathophysiologic pathways involved in PAH, including right heart structure and function, and their implications for diagnostic strategies
  • Evaluate the latest clinical safety and efficacy data for new and emerging PAH therapies to personalize treatment plans
  • Assess patient response to treatment and determine when to escalate therapy, including the integration of combination therapy, to optimize treatment goals
  • Leverage the unique role of an APP to bring quality of life, mental health, and shared decision-making into clinical practice to optimize patient treatment adherence and efficacy

ASCVD Prevention Through Individualized Pharmacologic and Supportive Care Management of Hyperlipidemia

  • Plan individualized, guideline-recommended lipid-lowering treatment strategies using nonstatin or combination therapies to improve patient outcomes
  • Design comprehensive, interprofessional, patient-centered care plans for individuals with or at risk for ASCVD that ensure optimal coordination and access for underserved patients
  • Educate patients and caregivers on the clinical rationale for nonstatin or combination therapies to treat hyperlipidemia, addressing concerns on side effects and providing strategies to promote compliance

Accreditation

Joint Accreditation Statement

In support of improving patient care, Partners for Advancing Clinical Education (Partners) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 2.0 contact hours, including 2.0 hours of pharmacotherapy credit.

Physician Associate Continuing Medical Education

Partners has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 2.00 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

IPCE Credit Designation

This activity was planned by and for the healthcare team, and learners will receive 2.0 Interprofessional Continuing Education (IPCE) credits for learning and change.

Disclosure of Conflicts of Interest
Partners requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships are mitigated according to Partners policies. 

Acknowledgement

Provided by

Provided by Partners for Advancing Clinical Education (Partners) in partnership with the the Academy of Physician Associates in Cardiology (APAC).

Partners for Advancing Clinical Education (Partners) 2025

Supporters

Leading With Impact: NPs and PAs at the Center of PAH Care Transformation
This activity is supported through an independent educational grant from Merck & Co., Inc., Rahway, NJ, USA.

ASCVD Prevention Through Individualized Pharmacologic and Supportive Care Management of Hyperlipidemia
TBA

Merck & Co., Inc., Rahway, NJ, USA

Partners

Academy of Physician Associates in Cardiology (APAC)

ProCE Banner

For customer support please click here.

Mailing Address:

 

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 304
Reston, VA 20191